Trades on 1 secondary market
Infinimmune
Infinimmune is a biotechnology company that discovers and engineers human-derived antibody therapeutics. Its Complete Human Sequencing and Anthrobody library-on-B-cell platform surface rare antibodies that evolution has already proven in people, and its GLIMPSE antibody language model characterizes
Infinimmune is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.